A three-judge panel of the Federal Circuit appeared split at oral argument on Dana-Farber Cancer Institute’s claims that a Nobel Prize winner’s fellow researchers should be named on his cancer immunotherapy patents.
Japan-based
U.S. Court of Appeals for the Federal Circuit Judges Alan D. Lourie and Kara F. Stoll had hard questions for the drug companies.
“The district court found that all three doctors ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.